TATDN3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.153400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.567400E-01
Normal-vs-Stage2
1.872210E-02
Normal-vs-Stage3
2.295700E-02
Normal-vs-Stage4
1.175820E-01
Stage1-vs-Stage2
9.680600E-03
Stage1-vs-Stage3
5.062500E-02
Stage1-vs-Stage4
2.761000E-01
Stage2-vs-Stage3
3.086800E-01
Stage2-vs-Stage4
5.757200E-01
Stage3-vs-Stage4
8.046100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.291000E-01
Normal-vs-AfricanAmerican
7.246800E-01
Normal-vs-Asian
1.033730E-02
Caucasian-vs-AfricanAmerican
3.033400E-01
Caucasian-vs-Asian
8.950000E-02
AfricanAmerican-vs-Asian
2.019000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.209210E-01
Normal-vs-Female
3.439400E-01
Male-vs-Female
3.376800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.344600E-01
Normal-vs-Age(41-60Yrs)
1.731570E-01
Normal-vs-Age(61-80Yrs)
2.528000E-01
Normal-vs-Age(81-100Yrs)
1.973180E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.704800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.896000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.019200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.926000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.050800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.546000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.576200E-02
Normal-vs-Daily Drinker
3.675800E-02
Normal-vs-Weekly Drinker
6.618200E-02
Normal-vs-Occasional Drinker
7.526200E-01
Normal-vs-Social Drinker
4.561200E-01
Non Drinker-vs-Daily Drinker
6.701200E-01
Non Drinker-vs-Weekly Drinker
9.232400E-01
Non Drinker-vs-Occasional Drinker
3.233400E-01
Non Drinker-vs-Social Drinker
4.293600E-01
Daily Drinker-vs-Weekly Drinker
6.395800E-01
Daily Drinker-vs-Occasional Drinker
2.486200E-01
Daily Drinker-vs-Social Drinker
3.079200E-01
Weekly Drinker-vs-Occasional Drinker
3.578000E-01
Weekly Drinker-vs-Social Drinker
4.869600E-01
Occasional Drinker-vs-Social Drinker
7.300200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.459600E-01
Normal-vs-Grade 2
5.825800E-02
Normal-vs-Grade 3
1.029230E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.638230E-02
Grade 1-vs-Grade 3
1.988220E-02
Grade 1-vs-Grade 4
2.459600E-01
Grade 2-vs-Grade 3
8.816800E-01
Grade 2-vs-Grade 4
5.825800E-02
Grade 3-vs-Grade 4
1.029230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.165700E-02
Normal-vs-NonDiabetic
2.972200E-01
Diabetic-vs-NonDiabetic
1.916190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.165900E-04
Normal-vs-NoPancreatitis
2.504000E-01
Pancreatitis-vs-NoPancreatitis
3.176200E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.961000E-01
Normal-vs-N1
1.023640E-02
N0-vs-N1
1.831590E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.034200E-02
Normal-vs-TP53-NonMutant
8.625000E-01
TP53-Mutant-vs-TP53-NonMutant
3.963500E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
